Sorafenib for advanced hepatocellular carcinoma (HCC): Impact of rationing in the United Kingdom

被引：1
|
作者：
Palmer, D. H. [1 ]
Hussain, S. A. [1 ]
Smith, A. J. [1 ]
Hull, D. [1 ]
Johnson, P. J. [1 ]
机构：
[1] Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14516
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of HCV treatment in patients with advanced hepatocellular carcinoma on sorafenib.
    Herman, Michael
    Zhang, Yuhua
    Wang, Lisa
    Sim, Hao-Wen
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
    Takada, Hitomi
    Kurosaki, Masayuki
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Itakura, Jun
    Tsuchiya, Kaoru
    Yasui, Yutaka
    Tamaki, Nobuharu
    Takaura, Kenta
    Komiyama, Yasuyuki
    Higuchi, Mayu
    Kubota, Youhei
    Wang, Wann
    Okada, Mao
    Enomoto, Nobuyuki
    Izumi, Namiki
    PLOS ONE, 2018, 13 (06):
  • [43] Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma
    Hideaki Takeyama
    Toru Beppu
    Takaaki Higashi
    Takayoshi Kaida
    Kota Arima
    Katsunobu Taki
    Katsunori Imai
    Hidetoshi Nitta
    Hiromitsu Hayashi
    Shigeki Nakagawa
    Hirohisa Okabe
    Daisuke Hashimoto
    Akira Chikamoto
    Takatoshi Ishiko
    Motohiko Tanaka
    Yutaka Sasaki
    Hideo Baba
    Surgery Today, 2018, 48 : 431 - 438
  • [44] Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma
    Takeyama, Hideaki
    Beppu, Toru
    Higashi, Takaaki
    Kaida, Takayoshi
    Arima, Kota
    Taki, Katsunobu
    Imai, Katsunori
    Nitta, Hidetoshi
    Hayashi, Hiromitsu
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Hashimoto, Daisuke
    Chikamoto, Akira
    Ishiko, Takatoshi
    Tanaka, Motohiko
    Sasaki, Yutaka
    Baba, Hideo
    SURGERY TODAY, 2018, 48 (04) : 431 - 438
  • [45] The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom
    Claxton, Lindsay
    Walton, Matthew
    Sharif-Hurst, Sahar
    Wade, Ros
    Eastwood, Alison
    Hodgson, Robert
    VALUE IN HEALTH, 2022, 25 (05) : 787 - 795
  • [46] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
    Feun, L. G.
    Levi, D.
    Moon, J.
    Nishida, S.
    Island, E.
    Selvaggi, G.
    Martin, P.
    Savaraj, N.
    Mendes, F.
    Tzakis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Nivolumab in sorafenib-naive and - experienced patients with advanced hepatocellular carcinoma (HCC): checkMate 040 study
    Trojan, J.
    Crocenzi, T. S.
    El-Khoueiry, A. B.
    Yau, T.
    Melero, I.
    Sangro, B.
    Kudo, M.
    Hsu, C.
    Kim, T. -Y.
    Choo, S. -P.
    Meyer, T.
    Kang, Y. -K.
    Yeo, W.
    Chopra, A.
    Baakili, A.
    dela Cruz, C.
    Lang, L.
    Neely, J.
    Welling, T. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 210 - +
  • [48] The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
    Wong, Hilda
    Tang, Yuen Fong
    Yao, Tzy-Jyun
    Chiu, Joanne
    Leung, Roland
    Chan, Pierre
    Cheung, Tan To
    Chan, Albert C.
    Pang, Roberta W.
    Poon, Ronnie
    Fan, Sheung-Tat
    Yau, Thomas
    ONCOLOGIST, 2011, 16 (12) : 1721 - 1728
  • [49] The effect of sorafenib (S) starting dose and dose intensity on survival in patients with advanced hepatocellular carcinoma (HCC)
    Alghamdi, Mohammed Abdullah
    Lee-Ying, Richard
    Swiha, Mina
    Chan, Kelvin K.
    Cheung, Winson Y.
    Ho, Maria
    Tam, Vincent C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [50] Treatment of advanced hepatocellular carcinoma: beyond sorafenib
    Meyer, Tim
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (04) : 218 - 220
12345